10000|3391|Public
5|$|Reactive neutrophilic {{cutaneous}} conditions {{constitute a}} spectrum of disease mediated by neutrophils, and typically associated with underlying diseases, such as <b>inflammatory</b> <b>bowel</b> <b>disease</b> and hematologic malignancy.|$|E
5|$|The {{presence}} of {{bacteria in the}} stomach may be beneficial, reducing the prevalence of asthma, rhinitis, dermatitis, <b>inflammatory</b> <b>bowel</b> <b>disease,</b> gastroesophageal reflux disease, and esophageal cancer by influencing systemic immune responses.|$|E
5|$|Nonpathogenic E. coli strain Nissle 1917, {{also known}} as Mutaflor, and E. coli O83:K24:H31 (known as Colinfant) are used as {{probiotic}} agents in medicine, mainly {{for the treatment of}} various gastroenterological diseases, including <b>inflammatory</b> <b>bowel</b> <b>disease.</b>|$|E
40|$|<b>Inflammatory</b> <b>bowel</b> <b>diseases</b> are {{a result}} of an {{aberrant}} mucosal immune response to gut microflora. Several groups have reported newly diagnosed <b>inflammatory</b> <b>bowel</b> <b>diseases</b> following solid organ transplantation and subsequent immunosuppressive therapy. We describe four cases of newly diagnosed <b>inflammatory</b> <b>bowel</b> <b>diseases</b> following liver transplantation in a pool of 120 transplanted patients. These patients had no prior history of <b>inflammatory</b> <b>bowel</b> <b>diseases</b> or primary sclerosing cholangitis and were immunosuppressed. Two patients were transplanted for a hepatitis C related cirrhosis, one for alcoholic cirrhosis and one patient for autoimmune cirrhosis. Three patients were diagnosed with ulcerative colitis and one with Crohn's disease. These four patients were on a cyclosporin monotherapy when their <b>inflammatory</b> <b>bowel</b> <b>diseases</b> were diagnosed. These data suggest that cyclosporin monotherapy following solid organ transplantation does not prevent development of <b>inflammatory</b> <b>bowel</b> <b>diseases...</b>|$|R
40|$|The {{growth rate}} of <b>inflammatory</b> <b>bowel</b> <b>diseases</b> among {{children}} actualizes early detection of this pathology form and its aftera effects, including secondary osteoporosis. The research purpose is to study the characteristics of osseous tissue mineralization, disorder of physical growth and sexual maturity of children, suffering from <b>inflammatory</b> <b>bowel</b> <b>diseases.</b> The researchers have examined 116 children, including 33 children, suffering from <b>inflammatory</b> <b>bowel</b> diseases; 26 children, suffering from persistent colitis; 29 children, suffering from gasatroduodenitis; and 28 children with no GI tract pathologies. The study deals with estimate of level of mineral osseous tissue density, biochemical rates of osseous metabolism, {{as well as physical}} growth and sexual maturity. reduction of mineral osseous tissue density was found among 48, 5 % of children, suffering from <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> 23 % of children, suffering from persistent colitis, 31 % of children, suffering from chronic gastritis and 18 % of almost healthy children, at the same time, it was more apparent among children, suffering from <b>inflammatory</b> <b>bowel</b> <b>diseases.</b> The lowest rates of mineral osseous tissue density were among girls. Calcium phosphoric metabolism did not change apart from calcium creatinine coefficient, if osteopenia was observed. Thus, reduction of mineral osseous tissue density is often observed among children, suffering from <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> especially among adolescent girls. Therefore, it conditions the necessity to include densimetry into the conventional examination plan for children, suffering from <b>inflammatory</b> <b>bowel</b> <b>diseases.</b> Authors also find it advisable to monitor physical growth and sexual maturity of children. Key words: children, <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> osteoporosis. </p...|$|R
40|$|Anemia {{is one of}} {{the most}} {{frequent}} complications of <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> which occur, according to various sources, in 6 – 74 % of patients with these forms of pathology. The pathogenesis and treatment of anemia in <b>inflammatory</b> <b>bowel</b> <b>diseases</b> have a number of peculiarities. Thus, for example, not every anemia — iron deficiency and, accordingly, its correction is limited to only iron administration.  The review analyzed the multifactorial nature of anemia in <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> its influence on the course, and prognosis of the main disease; modern therapeutic agents are described. </p...|$|R
5|$|Nephrotic syndrome, {{in which}} protein from the {{bloodstream}} is {{released into the}} urine due to kidney diseases, can predispose to thrombosis; this is particularly the case in more severe cases (as indicated by blood levels of albumin below 25g/l) and if the syndrome {{is caused by the}} condition membranous nephropathy. <b>Inflammatory</b> <b>bowel</b> <b>disease</b> (ulcerative colitis and Crohn's disease) predispose to thrombosis, particularly when the disease is active. Various mechanisms have been proposed.|$|E
5|$|Other {{potential}} {{causes of}} {{signs and symptoms}} that mimic those seen in gastroenteritis {{that need to be}} ruled out include appendicitis, volvulus, <b>inflammatory</b> <b>bowel</b> <b>disease,</b> urinary tract infections, and diabetes mellitus. Pancreatic insufficiency, short bowel syndrome, Whipple's disease, coeliac disease, and laxative abuse should also be considered. The differential diagnosis can be complicated somewhat if the person exhibits only vomiting or diarrhea (rather than both).|$|E
5|$|Gastrointestinal {{disorders}} are sometimes associated with aphthous-like stomatitis, e.g. most commonly Celiac disease, but also <b>inflammatory</b> <b>bowel</b> <b>disease</b> such as Crohn's disease or ulcerative colitis. The link between gastrointestinal disorders and aphthous stomatitis is probably related to nutritional deficiencies caused by malabsorption. Less than 5% {{of people with}} RAS have Celiac disease, which usually presents with severe malnutrition, anemia, abdominal pain, diarrhea and glossitis (inflammation of the tongue). Sometimes aphthous-like ulcerations can be {{the only sign of}} celiac disease. Despite this association, a gluten-free diet does not usually improve the oral ulceration.|$|E
40|$|Background Biologics {{are used}} for the {{treatment}} of <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> Crohn´s disease and ulcerative colitis refractory to conventional treatment. In order to allocate healthcare spend-ing efficiently, costly biologics for <b>inflammatory</b> <b>bowel</b> <b>diseases</b> are an important target for cost-effectiveness analyses. The aim {{of this study was to}} systemically review all published literature on the cost-effectiveness of biologics for <b>inflammatory</b> <b>bowel</b> <b>diseases</b> and to eval-uate the methodological quality of cost-effectiveness analyses. Methods A literature search was performed using Medline (Ovid), Cochrane Library, and SCOPUS. All cost-utility analyses comparing biologics with conventional medical treatment, another biologic treatment, placebo, or surgery {{for the treatment of}} <b>inflammatory</b> <b>bowel</b> <b>diseases</b> in adults were included in this review. All costs were converted to the 2014 euro. The method-ological quality of the included studies was assessed by Drummond’s, Philips’, and the Con...|$|R
2500|$|Immunological diseases, e.g., lupus erythematosus, sarcoidosis, <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> Kawasaki disease, Still disease, Horton disease, granulomatosis with polyangiitis, {{autoimmune}} hepatitis, {{relapsing polychondritis}} ...|$|R
3000|$|Radiological {{manifestations of}} <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> {{malabsorption}} syndrome and infection (BK) [...]...|$|R
5|$|Crohn's {{disease is}} a type of <b>inflammatory</b> <b>bowel</b> <b>disease</b> (IBD) that may affect any part of the {{gastrointestinal}} tract from mouth to anus. Signs and symptoms often include abdominal pain, diarrhea (which may be bloody if inflammation is severe), fever, and weight loss. Other complications may occur outside the gastrointestinal tract and include anemia, skin rashes, arthritis, inflammation of the eye, and tiredness. The skin rashes may be due to infections as well as pyoderma gangrenosum or erythema nodosum. Bowel obstruction also commonly occurs and those with the disease are at greater risk of bowel cancer.|$|E
5|$|Several {{other uses}} have been {{researched}} for bupropion. There has been controversy {{about whether it}} is useful to add an antidepressant such as bupropion to a mood stabilizer in people with bipolar depression, but recent reviews have concluded that bupropion in this situation does no significant harm and may sometimes give significant benefit. Bupropion has shown no effectiveness in the treatment of cocaine dependence, but there is weak evidence that it may be useful in treating methamphetamine dependence. Based on studies indicating that bupropion lowers the level of the inflammatory mediator TNF-alpha, there have been suggestions that it might be useful in treating <b>inflammatory</b> <b>bowel</b> <b>disease</b> or other autoimmune conditions, but very little clinical evidence is available. Bupropion—like other antidepressants, with the exception of duloxetine (Cymbalta)—is not effective in treating chronic low back pain. It does, however, show some promise in the treatment of neuropathic pain.|$|E
25|$|A {{recent study}} of <b>inflammatory</b> <b>bowel</b> <b>disease</b> and Coeliac disease found that anti-tTG was {{increased}} in <b>inflammatory</b> <b>bowel</b> <b>disease</b> although most cases were not clinical CD. IBD was increased 10 fold in coeliac disease. <b>Inflammatory</b> <b>bowel</b> <b>disease</b> consists of Crohn's disease, ulcerative colitis and microscopic colitis.|$|E
40|$|The {{burden of}} <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> {{including}} Crohn's disease and ulcerative colitis, {{has never been}} estimated in Italy using administrative data sources. Our objective was to measure the occurrence of <b>inflammatory</b> <b>bowel</b> <b>diseases</b> in the Lazio region (Italy) using administrative data and to test {{the sensitivity of the}} Crohn's disease case-finding algorithm with respect to clinical diagnosis...|$|R
40|$|BACKGROUND: The {{burden of}} <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> {{including}} Crohn's disease and ulcerative colitis, {{has never been}} estimated in Italy using administrative data sources. Our objective was to measure the occurrence of <b>inflammatory</b> <b>bowel</b> <b>diseases</b> in the Lazio region (Italy) using administrative data and to test {{the sensitivity of the}} Crohn's disease case-finding algorithm with respect to clinical diagnosis. METHODS: We conducted a population-based cross-sectional study identifying prevalent and incident cases. We estimated occurrence rates of <b>inflammatory</b> <b>bowel</b> <b>diseases</b> using hospital discharges or activation of copayment exemptions. Sensitivity was calculated from 2358 subjects with clinical diagnosis of Crohn's disease. RESULTS: Exemptions identified more than 20...|$|R
3000|$|... • In chronic <b>inflammatory</b> <b>bowel</b> <b>diseases</b> WE-MDCT {{depicts the}} distribution, mural and perivisceral changes.|$|R
25|$|Aspects under {{research}} include radiation-induced hemorrhagic cystitis; and <b>inflammatory</b> <b>bowel</b> <b>disease.</b>|$|E
25|$|A {{case report}} {{described}} <b>inflammatory</b> <b>bowel</b> <b>disease</b> {{in conjunction with}} Blastocystis infection.|$|E
25|$|There is a {{negative}} association of this DR15-DQ1 haplotype in Japanese with <b>inflammatory</b> <b>bowel</b> <b>disease.</b>|$|E
40|$|ABSTRACT- Context- The {{incidence}} and populational prevalence of <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> hitherto unknown in Brazil, were estimated for a {{region in the}} Midwest of São Paulo State, Brazil. Methods- Using a sequential registry of 115 adult patients (> 15 years old) with <b>inflammatory</b> <b>bowel</b> <b>diseases</b> – exclusively residing in the studied region with 533, 508 inhabitants (2005) and attended at the reference hospital during a 20 year interval (1986 - 2005) – were estimated, in four consecutives periods of 5 years each, the incidences according to gender, type {{of the disease and}} the prevalence of these diseases, and its inner-relations evaluated by the Poisson regression model. Results- The <b>inflammatory</b> <b>bowel</b> <b>diseases</b> in the studied region predominated among young, white race and people living in urban area, and the incidence on the female population rose during this period. The incidence of ulcerative colitis were higher than Crohn’s disease and non-classified colitis, and showed a progressive increase in the first three periods with a decrease in the last one (2001 - 2005), where the observed rates of ulcerative colitis, Crohn’s disease and non-classified colitis were 4. 48, 3. 50 and 1. 75 cases/ 100, 000 inhabitants, with prevalence of 22. 61, 14. 81, 5. 65, 2. 14 cases/ 100, 000 inhabitants for total <b>inflammatory</b> <b>bowel</b> <b>diseases.</b> Conclusion- The <b>inflammatory</b> <b>bowel</b> <b>diseases</b> incidence in the studied area was as low as in other countries of Latin America and smaller than that found in countries of South Europe. The crescent prevalence justifies the policies to adequate medical cares for <b>inflammatory</b> <b>bowel</b> <b>diseases</b> patients in this area...|$|R
50|$|The main {{diseases}} that cause an increased excretion of faecal calprotectin are <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> coeliac disease, infectious colitis, necrotizing enterocolitis, intestinal cystic fibrosis and colorectal cancer.|$|R
40|$|Crohn’s disease (CD) and {{ulcerative}} colitis (UC) are chronic <b>inflammatory</b> <b>bowel</b> <b>diseases</b> (IBD) that often involve organs {{other than those}} of the gastrointestinal tract. These nonintestinal affections are termed extraintestinal symptoms. Differentiating the true extraintestinal manifestations of <b>inflammatory</b> <b>bowel</b> <b>diseases</b> from secondary extraintestinal complications, caused by malnutrition, chronic inflammation or side effects of therapy, may be difficult. This review concentrates on frequency, clinical presentation and therapeutic implications of extraintestinal symptoms in <b>inflammatory</b> <b>bowel</b> <b>diseases.</b> If possible, extraintestinal manifestations are differentiated from extraintestinal complications. Special attention is given to the more recently described sites of involvement; i. e. thromboembolic events, osteoporosis, pulmonary involvement and affection of the central nervous system. © 2006 The WJG Press. All rights reserved...|$|R
25|$|Prenatal and {{childhood}} passive smoke exposure {{does not appear}} to increase the risk of <b>inflammatory</b> <b>bowel</b> <b>disease.</b>|$|E
25|$|Sulfasalazine, in {{addition}} to its use as an antibiotic, is also used in the treatment of <b>inflammatory</b> <b>bowel</b> <b>disease.</b>|$|E
25|$|Microscopic colitis, {{a type of}} <b>inflammatory</b> <b>bowel</b> <b>disease</b> where {{changes are}} only seen on {{histological}} examination of colonic biopsies.|$|E
40|$|<b>Inflammatory</b> <b>bowel</b> <b>diseases,</b> {{including}} Crohn's Disease and Ulcerative Colitis, {{result from}} a dysregulated inflammatory response to environmental factors in genetically predisposed individuals. The list of genetic factors involved {{in the development of}} these diseases has considerably increased in last years. However, recently, new promising insights on <b>inflammatory</b> <b>bowel</b> <b>diseases</b> have been produced by studies on microRNAs. MicroRNAs are small non coding RNA molecules, that play a pivotal role in gene expression and regulation. They are involved in many biological processes, such as cellular proliferation and differentiation, signal transduction and, more recently, they have been recognized as also having a role in the innate and adaptative response. In this review we give an overview on the role of microRNAs in the pathogenesis of <b>inflammatory</b> <b>bowel</b> <b>diseases...</b>|$|R
50|$|<b>Inflammatory</b> <b>bowel</b> <b>diseases</b> were {{described}} by Giovanni Battista Morgagni (1682-1771) and by Scottish physician T. Kennedy Dalziel in 1913.|$|R
50|$|Contraindications for {{macrogol}} taken orally as a laxative are intestinal perforation, <b>bowel</b> obstruction, ileus, <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> {{and toxic}} megacolon.|$|R
25|$|Researchers {{identify}} {{adult stem}} cells in the bone marrow that could one day be used to treat <b>inflammatory</b> <b>bowel</b> <b>disease</b> (IBD).|$|E
25|$|One {{example is}} common {{variable}} immunodeficiency (CVID) where multiple autoimmune diseases are seen, e.g.: <b>inflammatory</b> <b>bowel</b> <b>disease,</b> autoimmune thrombocytopenia and autoimmune thyroid disease.|$|E
25|$|The {{differential}} diagnosis includes colon cancer, <b>inflammatory</b> <b>bowel</b> <b>disease,</b> ischemic colitis, and irritable bowel syndrome, {{as well as}} a number of urological and gynecological processes.|$|E
40|$|<b>Inflammatory</b> <b>bowel</b> <b>{{diseases}}</b> (IBD) {{refer to}} two chronic diseases which involve {{the large and}} small intestines: ulcerative colitis and Crohn’s disease. The aim of the review {{is to focus on}} main oral signs which are related to a specific treatment. Most of the articles on IBD patients consider just the typical oral disease manifestations, without taking into account oral manifestations as results from the administrated treatment. Key words: <b>Inflammatory</b> <b>bowel</b> <b>diseases,</b> oral signs, treatmen...|$|R
40|$|AbstractAmong the extra-intestinal {{manifestations of}} <b>inflammatory</b> <b>bowel</b> <b>diseases,</b> those {{involving}} the lung are relatively rare. However, {{there is a}} wide array of such manifestations, spanning from drug-related pathologies to airway disease, fistulas, granulomatous diseases, autoimmune and thromboembolic disorders. Although infrequent, people dealing with <b>inflammatory</b> <b>bowel</b> <b>diseases</b> must be aware of these conditions, sometimes life-threatening, to avoid further impairment of the health status of the patients and to alleviate their symptoms by prompt recognition and treatment...|$|R
50|$|Altered {{function}} of dendritic cells {{is also known}} {{to play a major}} or even key role in allergy and autoimmune diseases like lupus erythematosus and <b>inflammatory</b> <b>bowel</b> <b>diseases</b> (Crohn's disease and ulcerative colitis).|$|R
